Company / Current Liabilities per Share
Cytek Biosciences, Inc. Current Liabilities per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.61
FY2025
5-year range
$0.37 / $1.06
FY2021-FY2025
Trend
+15.6%
vs FY2024
Sector context
#145 of 158
Health Care
What the data says
Among 158 Health Care companies, Cytek Biosciences, Inc. is in the top 8% for current liabilities per share. Current Liabilities per Share has increased for 3 consecutive years, from $0.37 in FY2022 to $0.61 in FY2025.
Based on SEC 10-K filings.
0.61 in FY2025 with a 5-year CAGR of -5.8%.
Increased from $0.43 to $0.61 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +18.2%
- 5-Year CAGR
- -5.8%
- 10-Year CAGR
- -
Sector benchmark
Top 8% in Health CareTop 8% of 158This company $0.61 Sector average $29.89
▼
-98.0% below sector average
Key checks
Key Insights
- Cytek Biosciences, Inc.'s current liabilities per share has grown for 3 consecutive years.
- In FY2025, current liabilities per share increased 15.6% year-over-year.
- Ranks #145 out of 158 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.61 | +15.6% |
| FY2024 | $0.52 | +21.7% |
| FY2023 | $0.43 | +17.3% |
| FY2022 | $0.37 | -65.5% |
| FY2021 | $1.06 | +30.5% |
| FY2020 | $0.81 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026